Tomovation means innovation

'A playground for new concepts and ideas'

In 2003, Michael Friebe PhD launched the holding company TOMOVATION (neatly combining tomography and innovation). Back in 1993, Dr Friebe was the founder of Neuromed AG, which at the time was the biggest provider and seller of mobile diagnostic services and refurbished MRI and CT systems in Central Europe. This firm was subsequently bought by UMS AG.

Photo: Tomovation means innovation

Tomovation has a special focus in all its business activities - medical imaging – and particularly MRI. Currently, the firm holds equity investments in 10 tomography companies. ‘The company is difficult to describe, as it is a playground for new concepts and ideas in MRI service operations, niche-market product development, and financing,’ Dr Friebe said. ‘It has a small sales operation for innovative niche-market products, and owns several MRI and CT imaging centres in Central Europe.’

Refurbished MRI services (and occasionally CT and PET) from de-installation through to re-installation – and everything in between - is provided worldwide via its subsidiary Tomosystems, which is ISO certified and approved by most OEM companies. This company is headed by Stefan Hellwig - an industry veteran - and supported by Bastian Berkel.

The Tomovation group holds over 10 MRI product-related patents and currently is developing devices for image guided surgery (through ITP) and MRI injectors (through Tomoinject), which even work with 7T MRI systems and already have won a prestigious design award.
In coming months, the R&D business will be complemented with dedicated investment activities in tomography start-up firms, to be managed by Oliver Lehmkuehler PhD.

Helped by innovative financing concepts and recently begun shared mobile MRI and PET services, Tomovation itself continues to invest in PET and MRI imaging centres.
Details:
Tomovation GmbH, Behringhauser Str. 31,
D-44575 Castrop-Rauxel
Phone: +49-2305-97322-0. Fax +49-2305-97322-99.

17.11.2006

More on the subject:

Related articles

Photo

News • Manganese MOF nanoparticles

New material to make MRI contrast agents greener, safer, sharper

Metal-organic frameworks (MOFs) serve as the basis for a novel type of MRI contrast agent, which the developers hope can outperform current agents while being less toxic for the patient.

Photo

News • Neuroscience and neuroimaging

AI brain atlas brings microscopic detail to MRI scans

Researchers developed an AI-assisted brain atlas for visualization at microscopic detail using MRI scans. The tool could transform early detection of Alzheimer's and other neurological diseases.

Photo

Article • Risk stratification initiatives in Europe and UK

The future of breast imaging: a date with density

About 60% women in Europe enrolled in a national breast cancer screening programme who have a screening mammogram can feel reasonably confident that radiologists will be able to diagnose early-stage…

Related products

Subscribe to Newsletter